Summary
Tacrolimus ointment is an effective treatment for atopic
dermatitis. As a calcineurin inhibitor, it works through the
FK-binding protein, inhibiting calcineurin and preventing
dephosphorylation of nuclear factor of activated T cells (NFAT).
Systemic absorption from the drug is minimal, allowing a favorable
safety profile. In head-to-head clinical trials with pimecrolimus,
tacrolimus proved to be a more effective treatment. Tacrolimus
ointment has also been compared to standard topical cortico-steroid
treatments and is equally effective if not superior to several
topical steroids. Overall, tacrolimus ointment is a safe and
effective treatment for atopic dermatitis and can be used as an
adjunctive treatment to standard management with topical
corticosteroids.